Attorneys said many questions remain about LDT regulation after the FDA lost its legal fight. A recent warning letter could be a clue to future enforcement.

Coating for the guidewires could come off and get left in patients, which could result in extended or additional procedures.

Quest plans to refine, develop and validate the technology and is aiming to launch the test in North America next year.

The recall comes more than one year after Medtronic announced it would exit the ventilator market.

Caris, which offers tools for disease diagnosis, therapy selection and treatment monitoring, is the latest company to test ...

Tandem will integrate its insulin delivery systems with a new dual glucose-ketone sensor being developed by Abbott.

Bomholt’s strategic leadership, international experience and ability to drive profitable growth and global expansion as ...

Kate Benedict joined Medtronic as president of the company’s acute care and monitoring business, the company announced Monday ...

The abrupt termination of the 17 panelists guiding the CDC’s vaccine recommendations could yield a new committee more aligned ...